Clinical Evidence And Outcome Assessment In Microneedling For Scars

https://en.wikipedia.org/wiki/Microneedles

The adoption of any therapy must rest on robust evidence. Is microneedling truly effective? Clinical data provides the answer.

1. Atrophic Scars (Acne Scars)

A 2019 RCT in the Journal of Cutaneous and Aesthetic Surgeryenrolled 60 patients with moderate-to-severe acne scars, comparing microneedling to topical tretinoin. After four sessions (monthly), 75% in the microneedling group achieved "good" or "excellent" improvement (Goodman Scar Grading Scale), versus only 15% in the control group. Gains remained stable at 6-month follow-up. A 2021 meta-analysis of 12 studies (486 patients) reported an overall efficacy rate of ~82% for microneedling, with mild adverse events (transient erythema, desquamation).

2. Hypertrophic Scars

A 2020 Lasers in Medical Sciencestudy compared microneedling + Triamcinolone versus Triamcinolone injection alone. Thirty patients per arm received three treatments. The combination group achieved a 68% reduction in scar height versus 41% in the injection group. Vancouver Scar Scale (VSS) improvement was 1.8-fold higher in the combo group. Crucially, pain scores were significantly lower (2.1/10 vs. 6.3/10), demonstrating enhanced efficacy andtolerability.

3. Keloids

Recurrence prevention is the primary challenge. A 2022 Dermatologic Surgeryprospective study on 42 ear keloid patients employed surgical excision followed immediately by microneedling with 5-FU/Triamcinolone infusion (monthly ×4). At 18-month follow-up, the recurrence rate was 9.5%-drastically lower than the 40–50% historical rate for surgery alone. This underscores microneedling's value in adjuvant drug delivery for keloid prophylaxis.

4. Safety Profile

Microneedling boasts a favorable safety profile. The most common AEs are mild, immediate erythema and edema, resolving within 24–48 hours. PIH occurs in ~5% of cases, typically transient and more common in darker skin types (Fitzpatrick IV-VI). Infection risk is negligible as the stratum corneum barrier remains largely intact. Unlike lasers or deep peels, microneedling carries minimal risk of worsening scars.

5. Outcome Measurement

Objective assessment tools include the Vancouver Scar Scale​ (pigmentation, pliability, height), ultrasonographic measurement​ of scar thickness, dermoscopy, and patient-reported outcome questionnaires. Advanced 3D imaging systems​ and high-frequency ultrasound​ now allow precise quantification of scar volume and texture changes, refining efficacy evaluations.

Data does not lie. High-quality research increasingly validates microneedling's efficacy in scar management. As larger, multicenter RCTs emerge, its role will only strengthen.